Genotoxic effect and nitrative DNA damage in HepG2 cells exposed to aristolochic acid

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 630, Issue 1-2, 2007, Pages 97-102

  Wu, Keya ^a   Jiang, Liping ^a   Cao, Jun ^a   Yang, Guang ^a   Geng, Chengyan ^a   Zhong, Laifu ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Aristolochic acid; Genotoxicity; HepG2 cells; Nitric oxide

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ARISTOLOCHIC ACID; DNA; NAPHTHALENE DERIVATIVE; NITRIC OXIDE; PEROXIDASE; PEROXYNITRITE; REACTIVE OXYGEN METABOLITE;

ARTICLE; CELL DISRUPTION; CELL MIGRATION; CELL STRAIN HEPG2; CHEMICAL CARCINOGENESIS; CHROMOSOME DISORDER; COMET ASSAY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA ADDUCT; DNA STRAND BREAKAGE; GENOTOXICITY; HUMAN; HUMAN CELL; IMMUNOPEROXIDASE STAINING; MICRONUCLEUS TEST; NITRATION; PRIORITY JOURNAL;

ARISTOLOCHIC ACIDS; CARCINOMA, HEPATOCELLULAR; COMET ASSAY; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MICRONUCLEUS TESTS; NITRIC OXIDE; PEROXYNITROUS ACID; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 34248547028     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2007.03.006     Document Type: Article

References (43)

1. Zhang H., Cifone M.A., Murli H., Erexson G.L., Mecchi M.S., and Lawlor T.E. Application of simplified in vitro screening tests to detect genotoxicity of aristolochic acid. Food Chem. Toxicol. 42 (2004) 2021-2028
2. Frei F.E., Würgler H., Juon C.B., and Hall U.G. Aristolochic acid is mutagenic and recombinogenic in Drosophila genotoxicity tests. Arch. Toxicol. 56 (1985) 158-166
3. Tsai L.H., Liu H.J., Yang C.P., and Chang C. Inactivation of Formosan snake venoms in vitro by the crude extract of Aristolochia radix. Taiwan Yi Xue Hui Za Zhi 74 (1975) 352-360
4. Grossgebauer K., Raettig H., Langmaack H., and Kuchler R. The induction of nonspecific resistance by lysozyme and aristolochia acid in bacterial and viral infections. Zentralbl Bakteriol [orig] 213 (1970) 401-415
5. Kupchan S.M., and Doskotch R.W. Tumor inhibitors. I. Aristolochic acid, the active principle of Aristolochia indica. J. Med. Pharmacol. Chem. 5 (1962) 657-658
6. Mose J.R. The effect of aristolochic acid on the development of methylcholanthrene tumors in mice. Osterreichische Kneipp-Magazin 2 (1975) 151-153
7. Hartwell J.C. Types of anticancer agents isolated from plants. Cancer Treatment Rep. 60 (1976) 1031-1067
8. Vanherweghem J.-L., Depierreux M., Tielemans C., Abramowicz D., Dratwa M., Vanhaelen-Fastre R., Jadoul M., Richard C., Vandervelde D., Verbeelen D., and Vanhaelen M. Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. The Lancet 341 (1993) 387-391
9. IARC, IARC Monographs on the Evaluation of Carcinogenic Risk to Humans. Some Traditional Herbal Medicines, Some Mycotoxins, Naphthalene and Styrene, IARC Press, Lyon, vol. 84, 2002, pp. 69-128.
10. Robisch G., Schimmer O., and Gggelmann W. Aristolochic acid is a direct mutagen in Salmonella typhimurium. Mut. Res. 105 (1982) 201-204
11. Schmeiser H.H., Pool B.L., and Wiessler M. Mutagenicity of the two main components of commercially available carcinogenic aristolochic acid in Salmonella typhimurium. Cancer Lett. 23 (1984) 97-101
12. Gotzl E., and Schimmer O. Mutagenicity of aristolochic acid (I, II) and aristolic acid I in new YG strains in Salmonella typhimurium highly sensitive to certain mutagenic nitroarenes. Mutagenesis 8 (1993) 17-22
13. Mengs U., and Klein M. Genotoxic effects of aristolochic acid in the mouse micronucleus test. Planta Med. 54 (1988) 502-503
14. Kevekordes S., Spielberger J., Burghaus C.M., Birkenkamp P., Zietz B., Paufler P., Diez M., Bolten C., and Dunkelberg H. Micronucleus formation in human lymphocytes and in the metabolically competent human hepatoma cell line Hep-G2: results with 15 naturally occurring substances. Anticancer Res. 21 (2001) 461-469
15. Pool B.L., Eisenbrand G., Preussmann R., Schlehofer J.R., Schmezer P., Weber H., and Wiessler M. Detection of mutations in bacteria and of DNA damage and amplified DNA sequences in mammalian cells as a systematic test strategy for elucidating biological activities of chemical carcinogens. Food Chem. Toxicol. 24 (1986) 685-691
16. Abel G., and Schimmer O. Induction of structural chromosomal aberrations and SCEs by aristolochic acid in human lymphocytes in vitro. Hum. Genet. 64 (1983) 131-133
17. Li Y., Liu Z., Guo X., Shu J., Chen J., and Li L. Aristolochic acid I-induced DNA damage and cell cycle arrest in renal tubular epithelial cells in vitro. Arch. Toxicol. 80 (2006) 524-532
18. Stiborová M., Sopko B., Hodek P., Frei E., Heinz H., and Schmeiser H.H. The binding of aristolochic acid I to the active site of human cytochromes P450 1A1 and 1A2 explains their potential to reductively activate this human carcinogen. Cancer Lett. 229 (2005) 193-204
19. Knasmuller S., Parzefall W., Sanyal R., Ecker S., Schwab C., Uhl M., Mersch-Sundermann V., Williamson G., Hietsch G., Langer T., Darroudi F., and Natarajan A.T. Use of metabolically competent human hepatoma cells for the detection of mutagens and antimutagens. Mutat. Res. 402 (1998) 185-202
20. Mersch-Sundermann V., Knasmuller S., Wu X.J., Darroudi F., and Kassie F. Use of a human-derived liver cell line for the detection of cytoprotective, antigenotoxic and cogenotoxic agents. Toxicology 198 (2004) 329-340
21. Kawanishi S., Hiraku Y., and Oikawa S. Mechanism of guanine-speciWc DNA damage by oxidative stress and its role in carcinogenesis and aging. Mutat. Res. 488 (2001) 65-76
22. Kawanishi S., Hiraku Y., Murata M., and Oikawa S. The role of metals in site-speciWc DNA damage with reference to carcinogenesis. Free Radic. Biol. Med. 32 (2002) 822-832
23. Lin W.C., Xue H.W., Liu S.Y., He Y.O., Fu J.L., and Zhou Z.C. Genotoxicity of nitric oxide produced from sodium nitroprusside. Mutat. Res. 413 (1998) 121-127
24. Kasai H., and Nishimura S. Hydroxylation of deoxyguanosine at the C8 position by ascorbic acid and other reducing agents. Nucleic Acids Res. 12 (1984) 2137-2145
25. Epe B. Genotoxicity of singlet oxygen. Chemico-Biol. Interact. 80 (1991) 239-260
26. Shosuke K., Yusuke H., and Shinji O. Mechanism of guanine-specific DNA damage by oxidative stress and its role in carcinogenesis and aging. Mutat. Res. 488 (2001) 65-76
27. Sumiko I., and Shosuke K. Oxidative DNA damage induced by simultaneous generation of nitric oxide and superoxide. FEBS Lett. 371 (1995) 86-88
28. Singh N.P., and Stephens R.E. Microgel electrophoresis: sensitivity, mechanisms and DNA electrostretching. Mutat. Res. 383 (1997) 167-175
29. Natarajan A.T., and Darroudi F.J. Use of human hepatoma cells for in vitro metabolic activation of chemical mutagens/carcinogens. Mutagenesis 5 (1991) 399-403
30. Misko T., Schilling R.J., Salvemini D., Moore W.M., and Currie M.G. A fluorometric assay for the measurement of nitrite in biological samples. Anal. Biochem. 214 (1993) 6-11
31. Yarborough A., Zhang Y.J., Hsu T.M., and Santella R.M. Immunoperoxidase detection of 8-hydroxydeoxyguanosine in aflatoxin B1-treated rat liver and human oral mucosal cells. Cancer Res. 56 (1996) 683-688
32. Nortier J.L., Muniz M.-C., Schmeiser H.H., Arlt V.M., Bieler C.A., Petein M., Depierreux M.F., Pauw L., Abramowicz D., Vereerstraeten P., and Vanherweghem J.-L. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia species). N. Engl. J. Med. 342 (2000) 1686-1692
33. Schneider H.H., Bieler C.A., Wiessler M., van Ypersele de Strihou C., and Cosyns J.-P. Detection of DNA adducts formed by aristolochic acid in renal tissue from patients with Chinese herbs nephropathy. Cancer Res. 56 (1996) 2025-2028
34. Bieler C.A., Stiborova M., Wiessler M., Cosyns J.-P., van Ypersele de Strihou C., and Schmeiser H.H. 32P-post-labelling analysis of DNA adducts formed by aristolochic acid in tissues from patients with Chinese herbs nephropathy. Carcinogenesis 18 (1997) 1063-1067
35. Routledge M.N., Orton T.C., Lord P.G., and Garner R.C. Effect of butylated hydroxyanisole on the level of DNA adduction by aristolochic acid in the rat forestomach and liver. Jpn. J. Cancer Res. 81 (1990) 220-224
36. Hiroshi O. Genetic and epigenetic damage induced by reactive nitrogen species: implications in carcinogenesis. Toxicol. Lett. 140-141 (2003) 99-104
37. Feldmeyer N., Schmeiser H.H., Muehlbauer K.-R., Belharazem D., Knyazev Y., Nedelko T., and Hollstein M. Further studies with a cell immortalization assay to investigate the mutation signature of aristolochic acid in human p53 sequences. Mutat. Res. 608 (2006) 163-168
38. Liu Z., Hergenhahn M., Schmeiser H.H., Wogan G.N., Hong A., and Hollstein M. Human tumor p53 mutations are selected for in mouse embryonic fibroblasts harboring a humanized p53 gene. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 2963-2968
39. Ignarro L.J. Biosynthesis and metabolism of endothelin derived nitric oxide. Annu. Rev. Pharmacol. Toxicol. 30 (1990) 535-560
40. Ignarro L.J., Fukuto I.M., Griscavage J.M., Rogers N.E., and Byrns R.E. Oxidation of nitric oxide in aqueous solution to nitrite but not nitrate: comparison with enzymatically formed nitric oxide from l-arginine. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 8103-8107
41. Sai K., Umemura T., Takagi A., Hasegawa R., and Kurokawa Y. The protective role of glutathione, cysteine and vitamin C against oxidative DNA damage induced in rat kidney by potassium bromate. Jpn. J. Cancer Res. 83 (1992) 45-51
42. Niles J.C., Burney S., Singh S.P., Wishnok J.S., and Tannenbaum S.R. Peroxynitrite reaction products of 3′, 5′-di-O-acetyl-8-oxo-7,8-dihydro-2′-deoxyguanosine. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 11729-11734
43. Sawa T., and Ohshima H. Nitrative DNA damage in inflammation and its possible role in carcinogenesis. Nitric Oxide 14 (2006) 91-100